Healthcare & Biotech
Eris Biotech
Our drugs engage the immune system to fight tumors
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
- Therapeutics
- Biotech
- Drug discovery
- Website
- erisbio.com
- Headquarters
- Salt Lake City, UT, USA
- Team size
- 2-10 people
- Founded
- 2024
- Demo
- Demo only
Similar companies
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.
Entelexo BiotherapeuticsCreating a New Class of Drugs to Address Incurable Autoimmune Diseases
Equator TherapeuticsWe are developing a drug to burn calories and increase metabolism…
Velorum TherapeuticsBreakthrough medicines unlocking the biology of heme
Sensible BiotechnologiesUnlocking the next generation of mRNA medicines
Serinus BiosciencesCombinations therapy by rational design
HepatxReplacing organ transplant with an infusion